2017
83 Antenatal Hormonal Therapy for Prevention of Respiratory Distress Syndrome
Gross I, Ballard P. 83 Antenatal Hormonal Therapy for Prevention of Respiratory Distress Syndrome. 2017, 825-830. DOI: 10.1016/b978-0-323-35214-7.00083-4.Chapters
2011
105 Hormonal Therapy for Prevention of Respiratory Distress Syndrome
Gross I, Ballard P. 105 Hormonal Therapy for Prevention of Respiratory Distress Syndrome. 2011, 1150-1156. DOI: 10.1016/b978-1-4160-3479-7.10105-3.Chapters
2007
Circulating stem cells in extremely preterm neonates
Bizzarro MJ, Bhandari V, Krause DS, Smith BR, Gross I. Circulating stem cells in extremely preterm neonates. Acta Paediatrica 2007, 96: 521-525. PMID: 17391470, DOI: 10.1111/j.1651-2227.2007.00194.x.Peer-Reviewed Original ResearchConceptsWeeks of lifePreterm neonatesNeonatal morbidityPulmonary functionPremature neonatesGestational agePeripheral bloodInitial CD34Median gestational agePulmonary function testsShort-term outcomesUmbilical cord bloodFunction testsNeonatal demographicsBirth weightCord bloodRespiratory diseaseNeonatesCell countCD34Progenitor cellsInverse correlationWeeksBloodMorbidityFetal Lung Development and Amniotic Fluid Analysis
Gross I, Bizzarro M. Fetal Lung Development and Amniotic Fluid Analysis. 2007, 83-92. DOI: 10.1002/9780470753293.ch6.ChaptersFetal Lung Development and Amniotic Fluid Analysis
Gross I, Bizzarro M. Fetal Lung Development and Amniotic Fluid Analysis. 2007, 24-27. DOI: 10.1002/9780470753323.ch6.Chapters
2005
Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
Bizzarro M, Gross I. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. 2005, cd005055. PMID: 16235391, DOI: 10.1002/14651858.cd005055.pub2.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsMean pulmonary arterial pressurePulmonary hypertensive crisisCongenital heart diseaseLong-term mortalityHeart diseasePulmonary hypertensionHeart rateHospital stayArterial pressureNitric oxidePostoperative managementMethodologic qualityMethaemoglobin levelsNeurodevelopmental disabilitiesEfficacy of iNOUse of iNOCochrane Central RegisterPulmonary arterial pressureSystemic blood pressureSubgroup of patientsHigh methodologic qualityMajority of outcomesMarkers of toxicityConventional managementHypertensive crisis
2004
Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
Bizzarro M, Gross I. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. 2004 DOI: 10.1002/14651858.cd005055.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsRest-Activity Patterns of Premature Infants Are Regulated by Cycled Lighting
Rivkees SA, Mayes L, Jacobs H, Gross I. Rest-Activity Patterns of Premature Infants Are Regulated by Cycled Lighting. Pediatrics 2004, 113: 833-839. PMID: 15060235, DOI: 10.1542/peds.113.4.833.Peer-Reviewed Original ResearchConceptsExperimental group infantsWeeks postmenstrual agePremature infantsPostmenstrual ageGroup infantsRest-activity patternsControl subjectsNeonatal intensive care unit roomsIntensive care unit roomsHospitalized premature infantsControl infantsDay-night rhythmHospital nurseryHead circumferenceDistinct patternsInfantsActivity patternsSolar light-dark cycleUnit roomsHospitalDim lightingAgeDay-night differenceMonthsDaysChapter 105 Hormonal Therapy for Prevention of Respiratory Distress Syndrome
Gross I, Ballard P. Chapter 105 Hormonal Therapy for Prevention of Respiratory Distress Syndrome. 2004, 1069-1074. DOI: 10.1016/b978-0-7216-9654-6.50108-9.Chapters
2001
Is there a role for antenatal TRH therapy for the prevention of neonatal lung disease?
Gross I, Moya F. Is there a role for antenatal TRH therapy for the prevention of neonatal lung disease? Seminars In Perinatology 2001, 25: 406-416. PMID: 11778911, DOI: 10.1053/sper.2001.29032.Peer-Reviewed Original ResearchConceptsAntenatal thyrotropin-releasing hormoneThyrotropin-releasing hormoneRespiratory distress syndromeSurfactant therapyDistress syndromeOxygen dependencyAntenatal glucocorticoid treatmentLight-headed feelingPatent ductus arteriosusRetinopathy of prematurityNeonatal lung diseaseRandomized clinical trialsPituitary-thyroid axisAddition of TRHAntenatal glucocorticoidsGlucocorticoid therapyMaternal therapyNeonatal complicationsTransient complicationsTRH therapyHormone therapyBlood pressureDuctus arteriosusGlucocorticoid treatmentLung disease
2000
Recent Advances in Respiratory Care of the Term Neonate
GROSS I. Recent Advances in Respiratory Care of the Term Neonate. Annals Of The New York Academy Of Sciences 2000, 900: 151-158. PMID: 10818401, DOI: 10.1111/j.1749-6632.2000.tb06225.x.ChaptersConceptsConventional ventilationLong-term neurologic outcomeHours of diagnosisNear-term infantsPersistent pulmonary hypertensionNitric oxide therapyChronic lung diseaseHigh-frequency ventilationHigh-frequency ventilatorNeurologic outcomePulmonary hypertensionTerm neonatesMembrane oxygenationRespiratory distressLung diseaseRespiratory careMajor causeTreatment regimesVentilationMorbidityInfantsTherapyMortalityHypertensionCyanosis
1998
Fetal Lung mRNA Levels of Hox Genes Are Differentially Altered by Maternal Diabetes and Butyrate in Rats
Jacobs H, Bogue C, Pinter E, Wilson C, Warshaw J, Gross I. Fetal Lung mRNA Levels of Hox Genes Are Differentially Altered by Maternal Diabetes and Butyrate in Rats. Pediatric Research 1998, 44: 99-104. PMID: 9667378, DOI: 10.1203/00006450-199807000-00016.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsButyratesButyric AcidDiabetes Mellitus, ExperimentalEmbryonic and Fetal DevelopmentFemaleGene Expression Regulation, DevelopmentalGenes, HomeoboxGestational AgeHistone Deacetylase InhibitorsLungOrgan Culture TechniquesPregnancyPregnancy in DiabeticsRatsRats, Sprague-DawleyRNA, MessengerTranscription, GeneticConceptsLung developmentLung explantsSurfactant apoproteinExperimental animalsLung mRNA levelsElevated levelsEffect of diabetesFetal rat lung explantsLungs of fetusesRat lung explantsEffect of butyrateAntenatal exposureMaternal diabetesMetabolic abnormalitiesStreptozotocin treatmentLower incidenceNormal ratsDiabetesDexamethasoneLevel of expressionRatsTreatment of explantsSodium butyrateMRNA levelsAlters expression
1997
Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn
Roberts J, Fineman J, Morin F, Shaul P, Rimar S, Schreiber M, Polin R, Zwass M, Zayek M, Gross I, Heymann M, Zapol W, Thusu K, Zellers T, Wylam M, Zaslavsky A. Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn. New England Journal Of Medicine 1997, 336: 605-610. PMID: 9032045, DOI: 10.1056/nejm199702273360902.Peer-Reviewed Original ResearchConceptsPersistent pulmonary hypertensionPulmonary vascular resistanceExtracorporeal membrane oxygenationPulmonary hypertensionSystemic oxygenationNitric oxideSevere hypoxemiaVascular resistanceMembrane oxygenationSystemic arterial hypoxemiaSystemic blood pressureLong-term therapyFull-term infantsNumber of deathsSystemic hypotensionArterial hypoxemiaBlood pressureMulticenter studyConventional therapyAlternative therapiesInvasive treatmentNitric oxide groupHypertensionInitial improvementMethemoglobin levels
1996
Retinoic acid increases surfactant protein mRNA in fetal rat lung in culture
Bogue CW, Jacobs HC, Dynia DW, Wilson CM, Gross I. Retinoic acid increases surfactant protein mRNA in fetal rat lung in culture. American Journal Of Physiology 1996, 271: l862-l868. PMID: 8944731, DOI: 10.1152/ajplung.1996.271.5.l862.Peer-Reviewed Original ResearchINHALED NITRIC OXIDE GAS IMPROVES OXYGENATION IN PPHN. • 1430
Roberts J, Fineman J, Morin F, Shaul P, Rimar S, Schreiber M, Polin R, Thusu K, Zayek M, Zwass M, Zellers T, Wylam M, Gross I, Zapol W, Heymann M. INHALED NITRIC OXIDE GAS IMPROVES OXYGENATION IN PPHN. • 1430. Pediatric Research 1996, 39: 241-241. DOI: 10.1203/00006450-199604001-01453.Peer-Reviewed Original Research
1994
Butyrate modulates surfactant protein mRNA in fetal rat lung by altering mRNA transcription and stability
Peterec S, Nichols K, Dynia D, Wilson C, Gross I. Butyrate modulates surfactant protein mRNA in fetal rat lung by altering mRNA transcription and stability. American Journal Of Physiology 1994, 267: l9-l15. PMID: 8048547, DOI: 10.1152/ajplung.1994.267.1.l9.Peer-Reviewed Original ResearchConceptsFetal rat lungButyric acid analogueMRNA concentrationsRat lungNa-butyrateSP-A levelsDiabetic pregnanciesMaternal diabetesPulmonary maturationLung maturationMRNA transcriptionBiphasic effectSurfactant protein mRNAsProtein mRNASP-B mRNAAcid analoguesButyrate treatmentLungExposure of explantsFetusesInitial decreaseMRNAGene expressionButyrateMaturationIdentification of Hox genes in newborn lung and effects of gestational age and retinoic acid on their expression
Bogue CW, Gross I, Vasavada H, Dynia DW, Wilson CM, Jacobs HC. Identification of Hox genes in newborn lung and effects of gestational age and retinoic acid on their expression. American Journal Of Physiology 1994, 266: l448-l454. PMID: 7909996, DOI: 10.1152/ajplung.1994.266.4.l448.Peer-Reviewed Original ResearchConceptsGestational ageReverse transcription-polymerase chain reactionNewborn mouse lungRat lung explantsMouse lungRetinoic acidMRNA levelsLung explantsRat lungFetal rat lung explantsEffects of RATranscription-polymerase chain reactionM retinoic acidTime-dependent increaseNewborn lungRA treatmentFetal miceLungRodent lungsSignificant doseHigher mRNA levelsFetal tissuesDivergent homeobox gene HexGene expressionPattern of expression
1993
Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences.
Moya F, Gross I. Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Seminars In Perinatology 1993, 17: 267-74. PMID: 8140441.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAntenatal steroidsPostnatal surfactantSurfactant therapyPostnatal surfactant therapyRespiratory distress syndromeSteroid therapyHormonal therapyDistress syndromePremature infantsTherapyNumber of centersEnd pointRoutine useSteroidsTRHMaturation profileApparent benefitPatientsInfantsDeathTerms of RDCLDWidespread useSyndromeComparable data
1992
Plasma Thyroid Hormones and Prolactin in Premature Infants and Their Mothers after Prenatal Treatment with Thyrotropin-Releasing Hormone
Ballard P, Ballard R, Creasy R, Padbury J, Polk D, Bracken M, Moya F, Gross I. Plasma Thyroid Hormones and Prolactin in Premature Infants and Their Mothers after Prenatal Treatment with Thyrotropin-Releasing Hormone. Pediatric Research 1992, 32: 673-678. PMID: 1287557, DOI: 10.1203/00006450-199212000-00009.Peer-Reviewed Original ResearchConceptsThyroid hormonesFree thyroxineThyrotropin-releasing hormone treatmentNewborn lung diseaseDoses of TRHMU/LPituitary-thyroid functionPlasma of womenThyrotropin-Releasing HormoneWk of gestationPmol/LPlasma thyroid hormonesCord TSHTRH i.Preterm fetusesCord concentrationsControl infantsPremature infantsPostnatal surgeTRH administrationLung diseaseCord bloodPrenatal treatmentTriiodothyronine levelsHormone treatmentANTENATAL TREATMENT WITH THYROTROPIN RELEASING HORMONE (TRH) FOR PREVENTION OF NEWBORN LUNG DISEASE
Ballard P, Ballard R, Creasy R, Gross I, Padbury J. ANTENATAL TREATMENT WITH THYROTROPIN RELEASING HORMONE (TRH) FOR PREVENTION OF NEWBORN LUNG DISEASE. Pediatric Research 1992, 32: 635-635. DOI: 10.1203/00006450-199211000-00183.Peer-Reviewed Original ResearchThyrotropin-Releasing HormoneChronic lung diseaseLung diseaseThyroid hormonesTRH therapyBirth weightFetal thyroid hormonesNewborn lung diseasePrenatal corticosteroid therapyLow birth weightPituitary-thyroid functionCord TSHCorticosteroid therapyAntenatal treatmentPreterm deliveryPremature infantsWk gestationFree T4Cord bloodSustained elevationReleasing HormoneSevere diseaseInfantsMaternal plasmaDisease